Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Carcinogenesis

Abstract #1213: Mapping neoplastic progression of ulcerative colitis by quantitative proteomics

Sheng Pan, Teresa Brentnall, Mary Bronner, David Crispin, Ruedi Aebersold, Peter Rabinovitch and Ru Chen
Sheng Pan
Univ. of Washington, Seattle, WA; Cleveland Clinic Foundation, Cleveland, OH; ETH-Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Teresa Brentnall
Univ. of Washington, Seattle, WA; Cleveland Clinic Foundation, Cleveland, OH; ETH-Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary Bronner
Univ. of Washington, Seattle, WA; Cleveland Clinic Foundation, Cleveland, OH; ETH-Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Crispin
Univ. of Washington, Seattle, WA; Cleveland Clinic Foundation, Cleveland, OH; ETH-Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ruedi Aebersold
Univ. of Washington, Seattle, WA; Cleveland Clinic Foundation, Cleveland, OH; ETH-Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Rabinovitch
Univ. of Washington, Seattle, WA; Cleveland Clinic Foundation, Cleveland, OH; ETH-Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ru Chen
Univ. of Washington, Seattle, WA; Cleveland Clinic Foundation, Cleveland, OH; ETH-Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published May 2009
  • Article
  • Info & Metrics
Loading
AACR Annual Meeting-- Apr 18-22, 2009; Denver, CO

Abstract

Patients with ulcerative colitis (UC) have an increased risk for developing colorectal cancer. The cancer risk is sufficiently elevated to require UC patients to have life-long colonoscopic surveillance every 1-2 years. Because UC tumorigenesis is associated with molecular field defects that can extend throughout the entire colon, including the non-dysplastic mucosa; we hypothesized that the same field defect will include abnormally expressed proteins. We applied proteomics to study the protein expression of UC neoplastic progression. The protein profiles of colonic epithelium were compared from 1) UC patients without dysplasia (non-progressors); 2) histologically normal-appearing colonic tissue of UC patient with high-grade dysplasia or cancer (progressors); 3) high-grade dysplastic tissue from UC progressors and 4) normal colon. We identified gradual protein dysregulation associated with UC neoplastic progression. Proteins relating to mitochondrion, oxidative activity, DNA repair, calcium ion binding were some of interesting classes of these dysregulated proteins. Network analysis discovered that Sp1 and c-myc proteins may play important roles in UC early and late stages of neoplastic progression, respectively. Finally, two up-regulated proteins in the non-dysplastic tissue of UC progressors, CPS1 and S100P, were further validated by IHC analysis. S100P could achieve 100% specificity and 80% sensitivity in distinguishing the non-dysplastic biopsies from progressors compared to non-progressors and normal colon. Our study provides insight into the molecular events associated with UC neoplastic progression, which could be exploited for the development of protein biomarkers in fields of non-dysplastic mucosa that identify a patient\#8217;s risk for UC dysplasia.

Citation Information: In: Proc Am Assoc Cancer Res; 2009 Apr 18-22; Denver, CO. Philadelphia (PA): AACR; 2009. Abstract nr 1213.

Footnotes

  • 100th AACR Annual Meeting-- Apr 18-22, 2009; Denver, CO

  • American Association for Cancer Research
Back to top
Cancer Research: 69 (9 Supplement)
May 2009
Volume 69, Issue 9 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract #1213: Mapping neoplastic progression of ulcerative colitis by quantitative proteomics
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Abstract #1213: Mapping neoplastic progression of ulcerative colitis by quantitative proteomics
Sheng Pan, Teresa Brentnall, Mary Bronner, David Crispin, Ruedi Aebersold, Peter Rabinovitch and Ru Chen
Cancer Res May 1 2009 (69) (9 Supplement) 1213;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract #1213: Mapping neoplastic progression of ulcerative colitis by quantitative proteomics
Sheng Pan, Teresa Brentnall, Mary Bronner, David Crispin, Ruedi Aebersold, Peter Rabinovitch and Ru Chen
Cancer Res May 1 2009 (69) (9 Supplement) 1213;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Carcinogenesis

  • Abstract LB-089: Defining windows of susceptibility for low-dose exposure to endocrine disruptors in rat mammary development by microRNA profiling
  • Abstract LB-086: Genes targeted by drugs and curcumin in a breast carcinogenesis model
  • Abstract LB-091: Characterization of molecular changes occurring during long-term treatment of human bronchial epithelial cells with cigarette smoke total particulate matter
Show more 3

Chemical and Environmental Carcinogenesis -- Poster Presentations - Proffered Abstracts

  • Abstract #1210: Modifying effects of diabetes mellitus in a rat multi-organ carcinogenesis model
  • Abstract #1207: Characterization of transformed LEC cells induced by arsenic
Show more 3
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement